Anti-CSMD1 monoclonal antibody

Pre-made anti-CSMD1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CSMD1/CSMD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0618-Ab-1/ GM-Tg-hg-IP0618-Ab-2Anti-Human CSMD1 monoclonal antibodyHuman
GM-Tg-rg-IP0618-Ab-1/ GM-Tg-rg-IP0618-Ab-2Anti-Rat CSMD1 monoclonal antibodyRat
GM-Tg-mg-IP0618-Ab-1/ GM-Tg-mg-IP0618-Ab-2Anti-Mouse CSMD1 monoclonal antibodyMouse
GM-Tg-cynog-IP0618-Ab-1/ GM-Tg-cynog-IP0618-Ab-2Anti-Cynomolgus/ Rhesus macaque CSMD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0618-Ab-1/ GM-Tg-felg-IP0618-Ab-2Anti-Feline CSMD1 monoclonal antibodyFeline
GM-Tg-cang-IP0618-Ab-1/ GM-Tg-cang-IP0618-Ab-2Anti-Canine CSMD1 monoclonal antibodyCanine
GM-Tg-bovg-IP0618-Ab-1/ GM-Tg-bovg-IP0618-Ab-2Anti-Bovine CSMD1 monoclonal antibodyBovine
GM-Tg-equg-IP0618-Ab-1/ GM-Tg-equg-IP0618-Ab-2Anti-Equine CSMD1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0618-Ab-1/ GM-Tg-hg-IP0618-Ab-2; GM-Tg-rg-IP0618-Ab-1/ GM-Tg-rg-IP0618-Ab-2;
GM-Tg-mg-IP0618-Ab-1/ GM-Tg-mg-IP0618-Ab-2; GM-Tg-cynog-IP0618-Ab-1/ GM-Tg-cynog-IP0618-Ab-2;
GM-Tg-felg-IP0618-Ab-1/ GM-Tg-felg-IP0618-Ab-2; GM-Tg-cang-IP0618-Ab-1/ GM-Tg-cang-IP0618-Ab-2;
GM-Tg-bovg-IP0618-Ab-1/ GM-Tg-bovg-IP0618-Ab-2; GM-Tg-equg-IP0618-Ab-1/ GM-Tg-equg-IP0618-Ab-2
Products NameAnti-CSMD1 monoclonal antibody
Formatmab
Target NameCSMD1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CSMD1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0618-Ag-1Recombinant multi-species CSMD1/ PPP1R24 protein


    Target information

    Target IDGM-IP0618
    Target NameCSMD1
    Gene ID64478,94109,364634,716670,100683465,101082560,526825,100064581
    Gene Symbol and SynonymsB930082H09,CSMD1,Mdcr1,mKIAA1890,PPP1R24
    Uniprot AccessionQ96PZ7
    Uniprot Entry NameCSMD1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183117
    Target ClassificationN/A

    The target: CSMD1, gene name: CSMD1, also named as PPP1R24. Predicted to act upstream of or within several processes, including learning or memory; mammary gland branching involved in pregnancy; and reproductive structure development. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.